Evidence map›Paper›PMID 42054406›Full record

ArticlePloS one2026

Treatment experiences and preferences of British South Asians living with recurrent depression.

Amirah Akhtar, Shabana Shafiq, Sahdia Parveen, Emmanuel Nwofe, Karen Windle

Abstract read
In one paragraph

Article in PloS one, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Amirah AkhtarDepartment of Applied Dementia Studies, University of Bradford, Bradford, United Kingdom.ORCID https://orcid.org/0000-0001-7371-5777
Shabana ShafiqFaculty of Health Studies, University of Bradford, Bradford, United Kingdom.
Sahdia ParveenDepartment of Applied Dementia Studies, University of Bradford, Bradford, United Kingdom.
Emmanuel NwofeDepartment of Applied Dementia Studies, University of Bradford, Bradford, United Kingdom.
Karen WindleSchool of Nursing and Paramedic Science, Ulster University, Belfast, United Kingdom.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionDepression is one of the leading causes of disability and is a highly recurrent condition. Recurrent depression has been associated with risk of suicide and greater morbidity. British South Asians are at greater risk of developing depression and face greater barriers to help-seeking and treatment uptake. To better support this population and reduce the risk of relapse it is important to explore treatment experiences and preferences.

aimsThis study explored the treatment experiences and preferences of 12 British South Asians living with recurrent depression.

methodsWe conducted semi-structured interviews and analysed the data using thematic analysis.

resultsPharmacological treatments were accompanied by a continuous lay evaluation process of the pros and cons. A preference for non-pharmacological interventions was found, particularly art-based, creative approaches. Interventions that were culturally adapted, with incorporation of religion were preferred. Barriers to recovery included inexperienced therapists and lack of support post-intervention to maintain durable effects of therapy. DISCUSSION: Health professionals, such as general practitioners and therapists, play a key role in shared decision making, to ensure people with recurrent depression feel supported and culturally appropriate treatment is offered. Managing recurrent depression, including reducing the risk of relapse can improve quality of life, wellbeing and reduce the risk of co-morbid conditions.

Indexed as

DepressionPatient PreferenceAdultAntidepressive AgentsFemaleHumansMaleMiddle AgedQuality of LifeRecurrenceSouth Asian PeopleUnited KingdomAntidepressive Agents

Identifiers

PMID42054406
PMCPMC13127911

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.